AI-Powered Patient Education for Comprehensive and Individualized Understanding for Patients
Go to Source This article was first shared by INDoximity This article was first shared by INDoximity: https://indoximity.com
Go to Source This article was first shared by INDoximity This article was first shared by INDoximity: https://indoximity.com
Go to Source This article was first shared by INDoximity This article was first shared by INDoximity: https://indoximity.com
The purpose of this American Gastroenterological Association (AGA) Institute Rapid Clinical Practice Update (CPU) Communication is to review the available evidence and provide expert advice regarding the evolving management of patients taking GLP-1 receptor agonists prior to endoscopy.
Go to Source This article was first shared by INDoximity This article was first shared by INDoximity: https://indoximity.com
Metoclopramide nasal spray (MNS) was developed as an alternative to oral metoclopramide. Prior phase 2 studies demonstrated efficacy in reducing symptoms in women, but not men with diabetic gastroparesis. The aim of this phase 3 study was to further determine the safety and efficacy of MNS compared to placebo in reducing symptoms of diabetic gastroparesis in women.